Want to see SHPH full AI Analyst Report?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Ratios
Shuttle Pharmaceuticals Holdings, Inc. Ratios
SHPH's free cash flow for Q2 2026 was $-531.64K. For the 2026 fiscal year, SHPH's free cash flow was increased by $36.00K and operating cash flow was $-567.64K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.06 | 1.44 | 5.37 | 8.79 | 0.23 |
| Quick Ratio | 0.06 | 1.44 | 5.37 | 8.79 | 0.23 |
| Cash Ratio | 0.04 | 1.25 | 2.47 | 8.63 | 0.23 |
| Solvency Ratio | -1.39 | -5.09 | -3.47 | -5.11 | -0.48 |
| Operating Cash Flow Ratio | -1.19 | -4.78 | -5.35 | -2.73 | -0.14 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -8.38 | -9.36 | -3.89 | -0.35 |
| Net Current Asset Value | $ -7.72M | $ 413.78K | $ 3.70M | $ 7.60M | $ -1.77M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.47 | 0.18 | 0.09 | 1.50 |
| Debt-to-Equity Ratio | 0.10 | 1.65 | 0.27 | 0.10 | -0.60 |
| Debt-to-Capital Ratio | 0.09 | 0.62 | 0.21 | 0.09 | -1.51 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 |
| Financial Leverage Ratio | 4.65 | 3.53 | 1.47 | 1.13 | -0.40 |
| Debt Service Coverage Ratio | -160.40 | -3.48 | -1.25 | -3.19 | -1.16 |
| Interest Coverage Ratio | -168.25 | -5.66 | -2.27 | -3.50 | -34.32 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.85 | 2.45 | 0.23 | 0.14 | 0.08 |
| Net Debt to EBITDA | 0.01 | 0.10 | 0.37 | 1.78 | -0.46 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 98.36% | 118.82% | 111.89% | 213.16% | 66.10% |
| Return on Assets (ROA) | -111.89% | -364.87% | -110.77% | -57.73% | -176.81% |
| Return on Equity (ROE) | -519.94% | -1289.54% | -162.55% | -65.07% | 70.76% |
| Return on Capital Employed (ROCE) | -474.95% | -791.36% | -120.02% | -30.53% | 111.32% |
| Return on Invested Capital (ROIC) | -460.77% | -403.38% | -106.02% | -27.82% | 268.46% |
| Return on Tangible Assets | -1846.70% | -364.87% | -110.77% | -57.73% | -176.81% |
| Earnings Yield | -397.58% | -4.12% | -0.46% | -0.12% | -0.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.05 | 0.07 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -7899.27 | -4969.82 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 7899.27 | 4969.82 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -57.89 | -7.10 | -0.35 | -0.26 | -0.02 |
| Free Cash Flow Per Share | -57.89 | -7.10 | -0.35 | -0.26 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -1896329.00 | 0.00 | -293.04 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -1896329.00 | 0.00 | -293.04 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -40.84 | -6.24 | -5.13 | -3.56 | -0.31 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -321.60% | -3.30% | -0.39% | -0.07% | -0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.25 | -0.02 | -219.56 | -812.16 | -90754.10 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.31 | 312.65 | 356.90 | 528.48 | -64221.38 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.31 | -30.26 | -258.48 | -1521.75 | -348146.34 |
| Price-to-Operating Cash Flow Ratio | -0.31 | -30.26 | -259.36 | -1521.75 | -348146.34 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | -5.99 | -3.73 | -2378.38 |
| Enterprise Value Multiple | -0.25 | -28.41 | -362.35 | -937.60 | -100490.29 |
| Enterprise Value | 2.85M | 220.97M | 1.45B | 4.05B | 104.56B |
| EV to EBITDA | -0.25 | -28.41 | -362.35 | -937.60 | -100490.29 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.30 | -30.16 | -258.21 | -1518.87 | -348147.92 |
| EV to Operating Cash Flow | -0.30 | -30.16 | -259.09 | -1518.87 | -348147.92 |
| Tangible Book Value Per Share | -46.32 | 0.69 | 0.25 | 0.74 | -0.12 |
| Shareholders’ Equity Per Share | 13.76 | 0.69 | 0.25 | 0.74 | -0.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -71.56 | -8.86 | -0.41 | -0.48 | -0.08 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.17 | 1.65 | 1.16 | 1.05 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.81 | 0.80 | 0.85 | 0.53 | 0.26 |
Currency in USD
